Literature DB >> 28687101

Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base.

Carlo M Contreras1, Chee Paul Lin2, Robert A Oster3, Sushanth Reddy4, Thomas Wang4, Selwyn Vickers4, Martin Heslin4.   

Abstract

BACKGROUND: We evaluated the role of lymph node (LN) retrieval in pancreatic adenocarcinoma (PA) patients undergoing pancreaticoduodenectomy (PD).
METHODS: We utilized the National Cancer Data Base; Cox regression models and logistic regression models were used for statistical evaluation.
RESULTS: We evaluated 26,792 patients with PA who underwent PD. The mean LN retrieved in LN(-) patients was 10.8 vs 14.4 for LN(+) patients (P < 0.0001). Greater LN retrieval is an independent predictor of a negative microscopic margin and decreased length of stay. The median survival of LN(-) patients exceeded that of LN(+) patients (24.5 vs 15.1 months, P < 0.0001). Increasing LN retrieval is a significant predictor of survival in all patients, and in LN(-) patients. The relationship of increased LN retrieval and enhanced survival is a nearly linear trend.
CONCLUSIONS: Rather than demonstrating an inflection point that defines the extent of adequate lymphadenectomy, this dataset demonstrates an incremental relationship between LN retrieval and survival.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymphadenectomy; National Cancer Data Base; Pancreatic cancer

Mesh:

Year:  2017        PMID: 28687101      PMCID: PMC5576522          DOI: 10.1016/j.amjsurg.2017.06.036

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  27 in total

1.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

2.  Statistics in brief: the importance of sample size in the planning and interpretation of medical research.

Authors:  David Jean Biau; Solen Kernéis; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

Review 3.  Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging.

Authors:  Sergio Pedrazzoli
Journal:  Cancer Treat Rev       Date:  2015-05-07       Impact factor: 12.111

4.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

5.  Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

6.  Lymph node evaluation for treatment of adenocarcinoma of the pancreas.

Authors:  Schelomo Marmor; Erin E Burke; Pamela R Portschy; Beth A Virnig; Eric H Jensen; Todd M Tuttle
Journal:  Surg Oncol       Date:  2015-08-07       Impact factor: 3.279

7.  Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

Authors:  Jaffer A Ajani; David J Bentrem; Stephen Besh; Thomas A D'Amico; Prajnan Das; Crystal Denlinger; Marwan G Fakih; Charles S Fuchs; Hans Gerdes; Robert E Glasgow; James A Hayman; Wayne L Hofstetter; David H Ilson; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; A Craig Lockhart; Kenneth Meredith; Mary F Mulcahy; Mark B Orringer; James A Posey; Aaron R Sasson; Walter J Scott; Vivian E Strong; Thomas K Varghese; Graham Warren; Mary Kay Washington; Christopher Willett; Cameron D Wright; Nicole R McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

8.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

9.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Daniel Laheru; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  6 in total

1.  Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.

Authors:  Rene Warschkow; Catherine Tsai; Nastassja Köhn; Suna Erdem; Bruno Schmied; Daniel P Nussbaum; Beat Gloor; Sascha A Müller; Dan Blazer; Mathias Worni
Journal:  Langenbecks Arch Surg       Date:  2020-02-10       Impact factor: 3.445

2.  A National Assessment of Optimal Oncologic Surgery for Distal Pancreatic Adenocarcinomas.

Authors:  Katherine Hrebinko; Samer Tohme; Richard S Hoehn; Samer AlMasri; Sidrah Khan; Christof Kaltenmeier; Kenneth K Lee; Alessandro Paniccia; Amer Zureikat; Ibrahim Nassour
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.327

3.  N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pancreatic Cancer?

Authors:  Dimitrios Prassas; Sami Alexander Safi; Maria Chara Stylianidi; Leila Anne Telan; Sarah Krieg; Christoph Roderburg; Irene Esposito; Tom Luedde; Wolfram Trudo Knoefel; Andreas Krieg
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

4.  The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma.

Authors:  Claudia Zaharia; Marcus Roalsø; Kjetil Søreide
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

Review 5.  Management of pancreatic head adenocarcinoma: From where to where?

Authors:  Kemal Dolay; Fatma Umit Malya; Sami Akbulut
Journal:  World J Gastrointest Surg       Date:  2019-03-27

6.  Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.

Authors:  Zhen-Jiang Zheng; Mo-Jin Wang; Chun-Lu Tan; Yong-Hua Chen; Jie Ping; Xu-Bao Liu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.